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Optical coherence tomography angiography (OCTA) is a relatively novel 
technology for in vivo imaging of vascular network. It uses moving 
erythrocytes as contrasting mechanism and avoids the use of intravenous 
dyes. A depth-resolved 3-dimensional image set can be generated within 
seconds using the technique of OCTA. Therefore, it possesses a great 
potential for widespread application in ophthalmic angiography. Herein we 
discuss the most common technologies behind OCTA and the scope of future 
technical improvement. We provide a perspective on advantages and 
disadvantages of OCTA over conventional fluorescein angiography and 
indocyanine green angiography. Lastly, current literature on the clinical 
application of OCTA in common ocular diseases including neovascular age-
related macular degeneration, diabetic retinopathy, retinal artery and vein 
occlusion, and glaucoma are reviewed.   
OCT has been a routinely used imaging modality in ophthalmology for the 
past 2 decades. Its ability to generate high-resolution (1-10 µm), depth-
resolved, cross-sectional images noninvasively has made OCT an ideal tool 
to decipher structural information of the eye. 
Recently, development of OCT angiography (OCTA) has added a new 
dimension of functional vascular network imaging to the existing capabilities of 
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OCT allowing it to image end-arterial system without the need of a dye 
injection.   
Current gold standard investigations for ophthalmic angiography include 
fluorescein angiography (FA) and indocyanine green angiography (ICGA). 
Both investigations require injection of intravenous dye, which is time-
consuming and carries the risk of allergic reaction. Fluorescein dye injection is 
a relative contraindication in certain systemic conditions such as pregnancy 
and renal impairment. Since fluorescein dye cannot diffuse through intact 
blood-retinal-barrier, it serves as an excellent tool for imaging retinal lesions. 
On the other hand, ICGA enables imaging of the deeper choroidal circulation 
below the retinal pigment epithelium. However, both FA and ICGA generate 2-
dimensional images of the retinal or choroidal circulation. This poses difficulty 
in localizing the depth and extent of lesions, especially in the presence of dye 
leakage or retinal hemorrhages.  
Swept source OCT (SS-OCT) uses a tunable swept laser, which enables the 
measurement of interference at different optical frequencies or wavelengths 
sequentially over time.[1] No spectrometer or line camera is needed for the 
Fourier transformation. This increases the imaging speed up to 300,000 axial 
scans per second and allows a deeper penetration of the sampling beam. It 
provides an axial resolution of 8 microns with transverse resolution of 20 
microns. SS-OCT offers several potential advantages over SD-OCT, including 
increased sensitivity through the full imaging depth, deeper penetration, 
decreased fringe washout, better axial resolution over a broad imaging range, 
and higher detection efficiencies. Being a longer length, it has potential to 
image choroid much better than conventional SD-OCT[1].  
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 L
on
do
n]
 at
 17
:33
 14
 M
ay
 20
16
 
 4 
 
OCTA is non-contact as well as non-invasive, and avoids dye-related 
complications such as anaphylaxis. Image acquisition is fast with one scan set 
of volumetric information obtained within seconds. OCTA generates a 3-
dimensional image set so that vascular plexuses at different depths can be 
visualized from internal limiting membrane up to choroid.  
 
OCT angiogram is reconstructed from a series of OCT b-scans taken in a very 
short time frame. A substantial number of OCTA methods have been 
proposed so far. In brief, these methods capitalize on the changes in phase 
and/or amplitude between OCT signals backscattered from moving 
erythrocytes and that from static tissue background in consecutively collected 
OCT b-scans. The most commonly used methods in ophthalmic OCTA can be 
broadly classified into 3 categories, i.e. complex OCT signal based, e.g. 
optical microangiography (OMAG) [2]; OCT signal amplitude based, e.g. 
amplitude decorrelation [3] and speckle variance; and OCT signal phase 
based, e.g. phase variance. Of note, two commercially available OCTA 
systems have now been approved by the Food and Drug Administration of the 
United States (US-FDA). The AngioVue system (Optovue, Inc, Fremont, CA) 
uses the split-spectrum amplitude-decorrelation angiography (SSADA) 
algorithm, while the AngioPlex system (Carl Zeiss Meditec Inc, Dublin, CA) 
employs the OMAG algorithm. Direct comparisons among OCTA methods is 
currently very limited and there is no consensus on whether any one is more 
superior [4]. However, since the OMAG algorithm has a unique ability of 
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 5 
mathematically mapping the backscattered optical signals from moving 
particles into one image, and static signals onto a second image 
simultaneously, this technique may provide better results since it uses the 
signal to the fullest extent. In addition, we also expect the development of new 
algorithms that combine merits of various methods to achieve better image 
quality [4]. Evolution of OCT devices is also making an impact on the OCTA 
improvement. As reported by Novais et al, Swept-source OCT appeared to 
demarcate lesion better compared to spectral domain OCT in evaluating 
choroidal neovascularization (CNV) [5]. 
Currently, literature on clinical applications of OCTA in determining endpoints 
in therapeutic clinical trials is lacking. Research is underway for the 
quantitative analysis of the information obtained by OCTA. This may be useful 
in providing more information on the effect of therapy on the disease process. 
Large prospective studies comparing OCTA with FA/ICGA in various disease 
entities are also required. There are ever increasing number of publications of 
OCTA in ophthalmic imaging in the last 2 years. In the index editorial, we will 
focus on the use of OCTA in common ocular diseases which may have large 
impact on the future of this technology.  
Neovascular age-related macular degeneration (AMD): Jia et al first reported 
OCTA was able to detect and quantify choroidal neovascularization (CNV) in 
5 eyes with AMD [6]. De Carlo et al showed a sensitivity of 50% (4 of 8) and 
specificity of 91% (20 of 22) when they compared OCTA and FA’s ability to 
detect CNV. This relatively low sensitivity was attributed to small sample size 
and presence of large retina hemorrhage [7]. Researchers also demonstrated 
the usefulness of OCTA in evaluating changes of CNV in response to 
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treatment [8,9]. However, both studies were of small sample size and did not 
evaluate whether features on OCTA could predict response to treatment.  
Diabetic retinopathy (DR): In a prospective pilot study, Ishibazawa et al 
demonstrated OCTA clearly depicted retina microvascular status in DR [10]. 
Changes in foveal avascular zone (FAZ) were described with OCTA in 113 
eyes from 65 patients by Di et al [11]. An automated algorithm for 
quantification of capillary nonperfusion using OCTA was shown to detect DR 
reliably compared to FA [12]. Most recently Bradley et al reported moderate 
agreement between OCTA and FA’s grading of diabetic macular ischemia [13]. 
Retina artery occlusion (RAO) and retina vein occlusion (RVO): OCTA 
features of RAO and RVO have been described in observational studies 
[14,15]. Of note, Nobre Cardoso et al used a standardized grading protocol to 
systemically compare OCTA to FA, and showed good agreement between the 
two in discerning vascular features in RVO [15]. 
Glaucoma: Angiography is not routinely performed in glaucoma. Jia et al 
proposed a novel measurement of optic disc perfusion using OCTA, which 
detected reduced perfusion in early glaucoma patients with 100% sensitivity 
and specificity [16]. The same group also demonstrated reduced peripapillary 
retina perfusion in glaucomatous eyes [17]. Using OCTA, Wang et al showed 
reduction in disc flow index correlated with glaucoma severity [18].  
 
OCTA features have also been described for central serous chorioretinopathy 
(CSC), dry AMD and other less common chorioretinal diseases showing 
abnormalities in superficial retinal, deep retinal and choroidal vasculature. 
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Among patients with CSC, it may be possible to have a higher detection rate 
of CNV compared to conventional dye-based FA [19]. Recognition of CNV in 
central serous retinopathy on FA is often challenging and likely to be missed, 
resulting in permanent photoreceptor and retinal pigment epithelial damage. 
Thus, OCTA may be useful in changing management practices and 
preserving vision in such patients. In addition to posterior segment imaging, 
OCTA has been adapted for anterior segment imaging and showed consistent 
and comparable results to ICGA [20].  
 
There are certain limitations of the existing OCTA system. As OCTA is 
essentially a snapshot of the vascular network at one point of time, dynamic 
information such as leakage is absent. Therefore, we are unable to 
differentiate between quiescent and active lesions on OCTA. Secondly, OCTA 
is dependent on erythrocytes movement as contrast mechanism. If blood flow 
is slower than detection threshold, e.g. in some microaneurysms and fibrotic 
CNV, it will not be visualized with OCTA. Thirdly, image acquisition area for 
current generation of OCTA systems is relatively small, ranging from 2x2 mm 
up to 12x12mm. However, wide-field OCTA covering more than 60º of the 
retina while maintain high definition and resolution has now become available 
[21]. Introduction of swept-source OCT with faster scanning speed has 
allowed for a wider field of view as demonstrated by Choi et al [22]. Montaging 
of multiple OCTA images is another strategy used to increase field of view. 
Fourthly, OCTA image artifact can arise from a few sources. Loss of fixation, 
patient movement and blinking all can cause motion artifacts. Projection 
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artifacts are observed when large retina vessels casting a shadow on deeper 
layers of the retina and choroid [23].  
 
OCTA is a novel angiographic imaging tool that has evolved rapidly in recent 
years. It is quick, non-invasive, dye-less and able to generate depth-resolved 
3-dimensional images of the vascular network. Although majority of the 
current literature on OCTA in ophthalmic imaging were observational case-
control studies, they consistently showed OCTA provided accurate detection 
and quantification of changes in the corneal, retinal and choroidal vasculature 
in common ocular diseases. In the future, OCTA can be improved with new 
algorithms that maximize signal-to-noise ratio and new OCT devices with 
faster scanning speed to expand the field of view may become commercially 
available. In order for OCTA to gain wider acceptance and routine use, large 
scale prospective studies are required to establish a normative database and 
to evaluate the sensitivity and specificity of OCTA compared to current 
standard FA and ICGA. The next step in determining the usefulness of OCTA 
may be evaluation of its clinical applications in assessing therapeutic effects 
of various treatment strategies in retinal and choroidal diseases. It remains to 
be seen how useful this technology is in clinical decision-making in conditions 
such as diabetic macular edema and CNV in AMD. Nonetheless, OCTA offers 
a non-invasive option of angiography that is valuable in the armamentarium of 
clinicians and researchers. 
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